Copy to clipboard 
RTI Surgical, announced a new agreement with Oxford Performance Materials (OPM), a supplier with a focus in advanced materials and additive manufacturing (3-D printing) for biomedical applications.
The agreement, effective Feb. 4, 2016, grants RTI an exclusive license to OPM’s OsteoFab® technology platform for spinal applications in all U.S. markets. OsteoFab is a next-generation implant manufacturing process that builds implantable medical devices, layer-by-layer, using only laser light and OPM’s OXPEKK® polymer. The OsteoFab process and OXPEKK material combine to create implants that are designed to enable bone ongrowth.
OXPEKK is a proprietary high-performance biocompatible polymer formulation from OPM, designed for medical applications. This strong, pure, radiolucent, hydrophilic, load-bearing material boasts a successful history in orthopaedic implant applications.
Under the agreement, OPM will manufacture RTI’s spinal implant designs using OsteoFab technology, and RTI will oversee finishing steps, packaging, marketing and distribution of finished products.
Source: RTI Surgical
The use of additive manufacturing continues to grow in the orthopaedic market. Stryker recently announced the construction of a state-of-the-art 3D printing manufacturing facility in order to produce new products across multiple divisions and set the company apart from its competitors.
